Answering Two Most Important Questions Surrounding Ampio Pharmaceuticals Inc (AMPE)

Ampio Pharmaceuticals Inc (NYSEMKT:AMPE) has recently reported topline from its PIVOT trial and the stock lost over 60% on the announcement last Thursday.

Keep Reading →